Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

NCT05969041 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Epithelial Tumors, Malignant

Interventions

DRUG: MT-302 (A)

Sponsor

Myeloid Therapeutics